ANI Pharmaceuticals Inc (ANIP)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,283,700 | 904,422 | 760,087 | 771,598 | 461,190 |
| Total stockholders’ equity | US$ in thousands | 428,530 | 457,599 | 338,540 | 358,740 | 195,700 |
| Financial leverage ratio | 3.00 | 1.98 | 2.25 | 2.15 | 2.36 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,283,700K ÷ $428,530K
= 3.00
The financial leverage ratio measures the proportion of a company's debt to its equity, indicating the extent to which the business relies on debt financing. The trend analysis of ANI Pharmaceuticals Inc's financial leverage ratio shows fluctuations over the past five years.
As of December 31, 2020, the financial leverage ratio was 2.36, indicating that the company had $2.36 of debt for every dollar of equity. Over the following years, the ratio decreased to 2.15 by December 31, 2021, and then increased to 2.25 by December 31, 2022.
However, by December 31, 2023, the financial leverage ratio dropped significantly to 1.98, suggesting a decrease in the company's dependence on debt. Interestingly, by December 31, 2024, the ratio spiked to 3.00, indicating a substantial increase in the proportion of debt relative to equity, which may raise concerns about the company's financial risk and stability.
Overall, although the trend in ANI Pharmaceuticals Inc's financial leverage ratio has been somewhat fluctuating, it is essential for stakeholders to monitor and assess the company's debt management strategies to ensure a healthy balance between debt and equity financing.
Peer comparison
Dec 31, 2024